Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul;57(7):1742-1753.
doi: 10.1038/s41588-025-02225-y. Epub 2025 Jun 25.

Single-cell and spatial transcriptomics of stricturing Crohn's disease highlights a fibrosis-associated network

Affiliations

Single-cell and spatial transcriptomics of stricturing Crohn's disease highlights a fibrosis-associated network

Lingjia Kong et al. Nat Genet. 2025 Jul.

Abstract

Fibrosis is a major complication of Crohn's disease (CD) marked by excess deposition of extracellular matrix, leading to stricturing and functional impairment. As mechanistic characterization and therapeutic options are lacking, we paired single-cell and spatial transcriptomics in 61 samples from 21 patients with CD and 10 patients without inflammatory bowel disease (IBD). Intestinal strictures were characterized by increased immune cells, including IgG+ plasma cells, CCR7-hi CD4+ T cells and inflammatory fibroblasts. Spatial transcriptomics showed that key subsets colocalize within diseased tissues and identified additional populations such as interstitial cells of Cajal and enteric neurons. Furthermore, we mapped gene expression onto intestinal biogeography, finding that known genetic risk loci are enriched within discrete spatial modules, defined by the presence of inflammatory fibroblasts and lymphoid follicles. Altogether, our datasets chart the key transcriptomic and cellular networks in stricturing CD and highlight the spatial organization of multicellular genetic risk factors.

PubMed Disclaimer

Conflict of interest statement

Competing interests: R.J.X. is cofounder of Jnana Therapeutics, Scientific Advisory Board member at Nestlé, Magnet BioMedicine and Arena BioWorks, and Board Director at MoonLake Immunotherapeutics; these organizations had no roles in this study. S.S. is currently an employee of Vertex Pharmaceuticals, which also had no role in this study. The other authors declare no competing interests.

References

    1. Lewis, J. D. et al. Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States. Gastroenterology 165, 1197–1205 (2023). - PubMed
    1. Graham, D. B. & Xavier, R. J. Pathway paradigms revealed from the genetics of inflammatory bowel disease. Nature 578, 527–539 (2020). - PubMed - PMC
    1. Kugathasan, S. et al. Prediction of complicated disease course for children newly diagnosed with Crohn’s disease: a multicentre inception cohort study. Lancet 389, 1710–1718 (2017). - PubMed - PMC
    1. D’Alessio, S. et al. Revisiting fibrosis in inflammatory bowel disease: the gut thickens. Nat. Rev. Gastroenterol. Hepatol. 19, 169–184 (2022). - PubMed
    1. Smillie, C. S. et al. Intra- and inter-cellular rewiring of the human colon during ulcerative colitis. Cell 178, 714–730 (2019). - PubMed - PMC

LinkOut - more resources